Special: America’s Rich Dumping Tech Stocks & Cash… and Buying THIS

  • Facebook
  • Twitter
  • Podcast

Debit spread

After news was released, shares of Seattle Genetics, Inc. (Nasdaq: SGEN) jumped more than 4.5%. Business Wire reported the reason behind the price move, “Seattle Genetics, Inc. and Astellas Pharma Inc. announced initial results from the phase 1 clinical trial EV-103. Forty-five patients were evaluated for safety with the combination...

Initial public offerings, or IPOs, can be frustrating to traders. They are often accompanied by hype and it is possible for traders to believe the hype. Unfortunately, the reality of the company’s prospects may not live up to the hype. This can result in the stock...